Barry Schechter

Barry Schechter

Chief Tech/Sci/R&D Officer at AmnioChor, Inc.

Net worth: 10 500 $ as of 31/03/2024

60 year
Consumer Services
Health Services
Health Technology

Profile

Barry Schechter is the founder of Pediavision, Inc. He is currently the Director-Cornea & External Disease Department at Florida Eye Microsurgical Institute, Inc. since 2005.
He is also the Medical Director at AmnioChor, Inc. His former position includes being an Independent Director at Innovation Pharmaceuticals, Inc. from 2014 to 2024.
Dr. Schechter's education includes an undergraduate degree from Brooklyn College and City University of New York, as well as a doctorate from State University of New York at Downstate Medical Center.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
28/09/2023 750,000 ( 0.15% ) 10 500 $ 31/03/2024

Barry Schechter active positions

CompaniesPositionStart
Corporate Officer/Principal 01/01/2005
Chief Tech/Sci/R&D Officer -
All active positions of Barry Schechter

Former positions of Barry Schechter

CompaniesPositionEnd
INNOVATION PHARMACEUTICALS INC. Director/Board Member 31/01/2024
Pediavision, Inc. Chief Executive Officer -
See the detail of Barry Schechter's experience

Training of Barry Schechter

Brooklyn College Undergraduate Degree
City University of New York Undergraduate Degree
State University of New York at Downstate Medical Center Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Barry Schechter's experience

Connections

13

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
INNOVATION PHARMACEUTICALS INC.

Health Technology

Private companies3

Health Services

Pediavision, Inc.

Health Services

See company connections
  1. Stock Market
  2. Insiders
  3. Barry Schechter